NCT04158453View on ClinicalTrials.gov

Safety, Blood Levels and Effects of AUT00201

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

December 14, 2020

Study Completion Date

December 24, 2020

Conditions
Healthy Volunteer
Interventions
DRUG

AUT00201

Oral dose of AUT00201

DRUG

Placebo

Oral dose of placebo

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors
All Listed Sponsors
lead

Autifony Therapeutics Limited

INDUSTRY

NCT04158453 - Safety, Blood Levels and Effects of AUT00201 | Biotech Hunter | Biotech Hunter